| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 36.33% | 47.86% | 38.50% | 12.50% | 2 | -27.10% | 2025-04-17 |
| 2 | 马云涛 | 国元证券 | 医药生物 | 36.33% | 104.04% | 24.44% | -17.65% | 1 | -47.07% | 2025-08-04 |
| 3 | 年庆功 | 国海证券 | 医药生物 | 36.28% | 37.78% | 29.95% | -25.00% | 5 | -18.14% | 2025-08-07 |
| 4 | 年庆功 | 国海证券 | 医药生物 | 36.27% | 37.78% | 28.82% | -25.00% | 5 | -18.14% | 2025-08-08 |
| 5 | 华挺 | 财通证券 | 医药生物 | 36.26% | 37.45% | 13.60% | -6.67% | 7 | -50.33% | 2025-07-16 |
| 6 | 刘浩 | 华创证券 | 医药生物 | 36.25% | 34.38% | 36.68% | 29.41% | 1 | -47.33% | 2025-04-18 |
| 7 | 韩世通 | 中信证券 | 医药生物 | 36.21% | 40.54% | 28.21% | -2.04% | 6 | -63.25% | 2025-07-15 |
| 8 | 王道 | 申万宏源 | 医药生物 | 36.17% | 35.60% | 37.61% | 33.33% | 4 | -42.73% | 2025-08-08 |
| 9 | 王班 | 民生证券 | 医药生物 | 36.15% | 39.09% | 27.76% | -21.43% | 15 | -61.25% | 2025-07-25 |
| 10 | 王斌 | 首创证券 | 医药生物 | 36.10% | 37.25% | 22.20% | 4.11% | 20 | -54.62% | 2025-08-08 |
| 11 | 杨松 | 天风证券 | 医药生物 | 36.09% | 38.92% | 26.31% | -40.89% | 19 | -72.65% | 2025-07-23 |
| 12 | 王斌 | 首创证券 | 医药生物 | 36.06% | 39.71% | 22.63% | 4.11% | 19 | -54.62% | 2025-07-28 |
| 13 | 仰佳佳 | 申万宏源 | 医药生物 | 36.05% | 35.94% | 3.59% | 23.08% | 1 | -37.64% | 2025-07-29 |
| 14 | 万鹏辉 | 国海证券 | 医药生物 | 35.99% | 33.34% | 19.08% | 50.00% | 5 | -3.00% | 2025-08-08 |
| 15 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 35.73% | 36.89% | 40.27% | 12.50% | 2 | -27.10% | 2025-04-03 |
| 16 | 张林晚 | 上海证券 | 医药生物 | 35.65% | 40.37% | 26.34% | -100.00% | 1 | -18.93% | 2025-07-22 |
| 17 | 刘浩 | 华创证券 | 医药生物 | 35.60% | 34.86% | 35.79% | 29.41% | 2 | -47.33% | 2025-05-16 |
| 18 | 韩世通 | 中信证券 | 医药生物 | 35.58% | 39.98% | 30.00% | -2.04% | 6 | -63.25% | 2025-07-16 |
| 19 | 韩世通 | 中信证券 | 医药生物 | 35.55% | 38.09% | 27.68% | -2.04% | 6 | -63.25% | 2025-07-14 |
| 20 | 仰佳佳 | 申万宏源 | 医药生物 | 35.55% | 35.44% | 20.78% | 23.08% | 1 | -37.64% | 2025-06-20 |